XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.2
FINANCIAL INSTRUMENTS (Tables)
 3 Months Ended
Jun. 30, 2025
Investments, All Other Investments [Abstract]  
SCHEDULE OF FINANCIAL INSTRUMENTS

 

  

As of

January 4, 2023

 
     
Derivative liabilities – Fair value of the Warrants  $3,858,521 
Derivative liabilities – Embedded conversion feature   1,247,500 
Convertible Notes   9,893,979 
   $15,000,000 
SCHEDULE OF CONVERTIBLE NOTES OBLIGATION

The Company’s Convertible Notes’ obligations were as the following for the three months ended June 30, 2025 and 2024:

 

   2025   2024 
   Three months ended 
   June 30, 
   2025   2024 
Carrying value – beginning balance  $2,900,160   $2,684,697 
Converted to ordinary shares   (2,290,408)   - 
Amortization of debt discount   66,222    682,648 
Deferred debt discount and cost of issuance   416,667    261 
Interest charge   69,563    151,393 
Carrying value – ending balance  $1,162,204   $3,518,999 
SCHEDULE OF DERIVATIVE LIABILITIES

The Company’s derivative liabilities were as the following for the three months ended March 31, 2025 and 2024:

 

   2025   2024 
   Three months ended June 30, 
   2025   2024 
Derivative liabilities –Warrants  $   $- 
Beginning balance   989,852    251,657 
Marked to the market   (251,657)   (134,217)
Ending fair value   738,195    117,440 
           
Derivative liabilities – Embedded conversion feature          
Beginning balance   1,782,498    36,298 
Converted to ordinary shares   (1,572,238)   - 
Remeasurement on change of convertible price   19,457    (261)
Marked to the market   (201,792)   - 
Ending fair value   27,925    36,037 
           
Total Derivative fair value at end of period  $766,120   $153,477